BioNTech and its U.S. partner Pfizer have already begun manufacturing Covid-19 boosters that are adapted for multiple Omicron ...

BioNTech and Pfizer announced trials this month for their adapted COVID-19 vaccines, to fight faster-spreading Omicron ...

The small-scale study is part of the companies’ efforts to update their vaccine in time for a potential fall vaccination ...

BioNTech, with its partner Pfizer, expects to begin deliveries of two omicron-adapted vaccines as soon as October in time for ...

July 31, 2022 -- The Biden administration plans to begin a COVID-19 booster campaign with reformulated ... In late June, Pfizer-BioNTech also announced a $3.2 billion agreement with the U.S ...

4/5-containing vaccine it’s developing with BioNTech BNTX ... He told investors that Pfizer and the FDA have agreed that the application for the updated booster will include “safety and ...

The Biden administration plans to offer updated Covid booster shots ... purchased 105 million bivalent Covid vaccine booster doses from Pfizer-BioNTech for potential use later this year.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind Phase ...

Second quarter revenues of EUR3.2 billion1, net profit of EUR1.7 billion and fully diluted earnings per share of EUR6.45 ($6.872) as well as first half ...

NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind ...

NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE ... kinds of immunocompromise a single booster dose to individuals 5 through 11 years of age who have completed a primary series with ...

NEW YORK and MAINZ, Germany, July 27, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer ...